This site is intended for healthcare professionals only
This conference was developed by the PCDS in conjunction with OmniaMed Communications. The sponsoring companies have had no input into the conference agenda, speaker selection or presentations, with the exception of the symposium sessions, for which the respective sponsoring companies are fully responsible.
The presentations for the 13th Welsh Conference of the Primary Care Diabetes Society (PCDS) are now available on-demand. Originally broadcast on 12 May 2022 in Cardiff.
Organised by the PCDS, the only association solely committed to the needs of primary care diabetes, the conference examined diabetes care from a Welsh perspective. Through a mixture of lectures and masterclasses, the event provided practical guidance to healthcare professionals, focusing on those issues that impact the most on everyday diabetes practice in Wales.
As the Welsh representatives of the PCDS Committee, we were delighted to be delivering an event that provided an invaluable opportunity for us to come together and discuss the real core issues in day-to-day diabetes care delivery in Wales.
We hope you find these online resources valuable.
AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three therapy areas – Oncology, Cardiovascular, Renal & Metabolism and Respiratory. AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide.
AstraZeneca operates in five different locations in the UK, where around 8,300 employees work in research and development, manufacturing, supply, sales and marketing. We supply 40 different medicines to the NHS. The UK is also an important location for AstraZeneca’s clinical trials; in 2018, there were 201 trials at 376 centres in the UK, involving over 7,000 patients. For more information, please visit www.astrazeneca.co.uk
Lilly is a global healthcare leader that unites caring with discovery to create medicines that make life better for
people around the world. We were founded in 1876 by a man committed to creating high-quality medicines that
meet real needs, and today we remain true to that mission.
This conference was developed by the PCDS in conjunction with OmniaMed Communications. The sponsoring companies have had no input into the conference agenda, speaker selection or presentations, with the exception of the symposium sessions, for which the respective sponsoring companies are fully responsible.
Sign up to all DiabetesontheNet journals
Journals
Sign up to all DiabetesontheNet journals
By clicking ‘Subscribe’, you are agreeing that DiabetesontheNet.com are able to email you periodic newsletters. You may unsubscribe from these at any time. Your info is safe with us and we will never sell or trade your details. For information please review our Privacy Policy.
Are you a healthcare professional? This website is for healthcare professionals only. To continue, please confirm that you are a healthcare professional below.
We use cookies responsibly to ensure that we give you the best experience on our website. If you continue without changing your browser settings, we’ll assume that you are happy to receive all cookies on this website. Read about how we use cookies.
